Autopsy report · NCT00268151

Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer

“Study was terminated due to lack of funding.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months after it had already started.
• 24 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of Louisville

Sponsor type

University, hospital or other

Conditions

Carcinoma, Non-Small Cell Lung

Interventions

Oxaliplatin; Capecitabine

Participants

24

Sites

1

Countries

United States

Trials that died the same way

• 3D X-ray Motion Analysis of Ankle-foot Motion After Total Ankle Arthroplasty
  “Study was terminated due to lack of funding and unforeseen delays.” (96% match in meaning)
• Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX
  “Study terminated due to inadequate funding.” (95% match in meaning)
• A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures
  “Study Terminated due to lack of Funding” (94% match in meaning)
• Therapeutic Exercise in Patients With Hemophilia
  “The Study was terminated due to lack of funding for continuing” (94% match in meaning)
• PET Imaging of Extrathalamic α4β2-nicotinic Acetylcholine Receptors in Health and Disease With [18F]XTRA
  “We terminated the study due to lack of funding” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.